mPEG8-bromide is a methoxy-terminated polyethylene glycol bromide reagent featuring a short PEG chain that terminates in a bromide leaving group. Structurally, it provides a flexible, hydrophilic spacer and a reactive handle for nucleophilic substitution, enabling quantitative installation of PEG segments onto electrophilic or nucleophilic partners depending on the synthetic strategy. In PROTAC and targeted degradation linker design, PEG-based spacers are commonly used to tune solubility, reduce nonspecific hydrophobic interactions, and modulate effective distance and conformational freedom between the ligand-binding moieties. The bromide functionality allows attachment to complementary fragments (for example, via substitution with suitable nucleophiles) to generate PEGylated linkers that can improve handling and aqueous compatibility of multicomponent degraders. This makes mPEG8-bromide a practical building block for constructing linker architectures that support systematic structure–activity relationship studies in targeted protein degradation research.
Structure of 1056881-04-9
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
This mPEG8-bromide is a polyethylene glycol-based brominated linker designed to support the modular synthesis of PROTAC conjugates. Its ether-rich, flexible scaffold can improve solubility and bioconjugation handling while providing a reactive bromide handle for controlled attachment to targeting ligands. The following points describe the linker’s structure and the practical reactivity considerations for assembling PROTAC architectures in a research setting.
Structure: The molecule comprises a methoxy-terminated poly(ethylene glycol) chain bearing a terminal bromide. It features repeating ether linkages that confer conformational flexibility, low polarity, and favorable hydrophilicity. The terminal C–Br bond serves as a leaving group for substitution, while the ether oxygen atoms stabilize solvated intermediates.
Reactivity: The bromide enables nucleophilic substitution under standard alkylation conditions used for PEG-linker installation in bioconjugation workflows. Suitable nucleophiles include amines or thiolates derived from functionalized targeting ligands, typically generated under mildly basic conditions. Polar aprotic solvents such as DMF or DMSO are commonly employed to promote SN2 reactivity, with temperature and stoichiometry tuned to minimize side reactions like elimination.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.